Cargando…

The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China

BACKGROUND: The cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) gene is expressed in the vascular endothelium, which metabolizes arachidonic acid into 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs). 20-HETE mediates cardiovascular homeostasis and growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Jin-Guo, Ma, Yi-Tong, Xie, Xiang, Yang, Yi-Ning, Pan, Shuo, Adi, Dilare, Liu, Fen, Chen, Bang-Dang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175619/
https://www.ncbi.nlm.nih.gov/pubmed/25189712
http://dx.doi.org/10.1186/1476-511X-13-145
_version_ 1782336510773690368
author Zou, Jin-Guo
Ma, Yi-Tong
Xie, Xiang
Yang, Yi-Ning
Pan, Shuo
Adi, Dilare
Liu, Fen
Chen, Bang-Dang
author_facet Zou, Jin-Guo
Ma, Yi-Tong
Xie, Xiang
Yang, Yi-Ning
Pan, Shuo
Adi, Dilare
Liu, Fen
Chen, Bang-Dang
author_sort Zou, Jin-Guo
collection PubMed
description BACKGROUND: The cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) gene is expressed in the vascular endothelium, which metabolizes arachidonic acid into 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs). 20-HETE mediates cardiovascular homeostasis and growth response in vascular smooth muscle cells (VSMCs) as well as the anti-platelet effect. EETs are potent endogenous vasodilators and inhibitors of vascular inflammation. This study assessed the association between human CYP1A1 gene polymorphisms and coronary artery disease (CAD) in the Uygur and Han in China. METHODS: Two independent case–control studies that recruited Han (389 patients with CAD and 411 controls) and Uygur participants (293 patients with CAD and 408 controls) analyzed the relationship between CYP1A1 single nucleotide polymorphisms (SNPs: rs4886605, rs12441817, rs4646422 and rs1048943) and CAD. All patients with CAD and controls were genotyped for the four SNPs of CYP1A1 using TaqMan SNP genotyping assays. RESULTS: In the Uygur group, the distribution of the dominant model(CC vs CT + TT) of rs4886605 for the total sample and the males was significantly different between CAD patients and control participants (P = 0.001 and P = 0.012, respectively), The difference remained significant after a multivariate adjustment (P = 0.018, P = 0.015, respectively). The rs12441817 was also associated with CAD in a dominant model for all participants (P = 0.003) and men (P = 0.012), and the difference remained significant after a multivariate adjustment (P = 0.016, P = 0.002, respectively). However, we did not observe differences in the Uygur females and Han group with regard to the allele frequency or genotypic distribution of rs4886605 and rs12441817 between patients with CAD and control participants. Patients with CAD did not significantly differ from the control participants with regard to the distributions of rs4646422 and rs1048943 genotypes, the dominant model, the recessive model, or allele frequency in the Han and Uygur groups. CONCLUSION: Both rs4886605 and rs12441817 SNPs of the CYP1A1 gene are associated with CAD in the Uygur population of China.
format Online
Article
Text
id pubmed-4175619
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41756192014-09-27 The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China Zou, Jin-Guo Ma, Yi-Tong Xie, Xiang Yang, Yi-Ning Pan, Shuo Adi, Dilare Liu, Fen Chen, Bang-Dang Lipids Health Dis Research BACKGROUND: The cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) gene is expressed in the vascular endothelium, which metabolizes arachidonic acid into 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs). 20-HETE mediates cardiovascular homeostasis and growth response in vascular smooth muscle cells (VSMCs) as well as the anti-platelet effect. EETs are potent endogenous vasodilators and inhibitors of vascular inflammation. This study assessed the association between human CYP1A1 gene polymorphisms and coronary artery disease (CAD) in the Uygur and Han in China. METHODS: Two independent case–control studies that recruited Han (389 patients with CAD and 411 controls) and Uygur participants (293 patients with CAD and 408 controls) analyzed the relationship between CYP1A1 single nucleotide polymorphisms (SNPs: rs4886605, rs12441817, rs4646422 and rs1048943) and CAD. All patients with CAD and controls were genotyped for the four SNPs of CYP1A1 using TaqMan SNP genotyping assays. RESULTS: In the Uygur group, the distribution of the dominant model(CC vs CT + TT) of rs4886605 for the total sample and the males was significantly different between CAD patients and control participants (P = 0.001 and P = 0.012, respectively), The difference remained significant after a multivariate adjustment (P = 0.018, P = 0.015, respectively). The rs12441817 was also associated with CAD in a dominant model for all participants (P = 0.003) and men (P = 0.012), and the difference remained significant after a multivariate adjustment (P = 0.016, P = 0.002, respectively). However, we did not observe differences in the Uygur females and Han group with regard to the allele frequency or genotypic distribution of rs4886605 and rs12441817 between patients with CAD and control participants. Patients with CAD did not significantly differ from the control participants with regard to the distributions of rs4646422 and rs1048943 genotypes, the dominant model, the recessive model, or allele frequency in the Han and Uygur groups. CONCLUSION: Both rs4886605 and rs12441817 SNPs of the CYP1A1 gene are associated with CAD in the Uygur population of China. BioMed Central 2014-09-05 /pmc/articles/PMC4175619/ /pubmed/25189712 http://dx.doi.org/10.1186/1476-511X-13-145 Text en © Zou et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zou, Jin-Guo
Ma, Yi-Tong
Xie, Xiang
Yang, Yi-Ning
Pan, Shuo
Adi, Dilare
Liu, Fen
Chen, Bang-Dang
The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title_full The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title_fullStr The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title_full_unstemmed The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title_short The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
title_sort association between cyp1a1 genetic polymorphisms and coronary artery disease in the uygur and han of china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175619/
https://www.ncbi.nlm.nih.gov/pubmed/25189712
http://dx.doi.org/10.1186/1476-511X-13-145
work_keys_str_mv AT zoujinguo theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT mayitong theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT xiexiang theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT yangyining theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT panshuo theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT adidilare theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT liufen theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT chenbangdang theassociationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT zoujinguo associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT mayitong associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT xiexiang associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT yangyining associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT panshuo associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT adidilare associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT liufen associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina
AT chenbangdang associationbetweencyp1a1geneticpolymorphismsandcoronaryarterydiseaseintheuygurandhanofchina